Perrigo (PRGO) Net Equity Issued and Repurchased (2013 - 2019)
Perrigo's (PRGO) quarterly Net Equity Issued and Repurchased came in at $200000.0 in Q4 2019, down 33.33% year-on-year from $300000.0 in Q4 2018, and down 50.0% on a QoQ basis from $400000.0 in Q3 2019.
Perrigo (PRGO) Net Equity Issued and Repurchased (2013 - 2019) Analysis & Trends
Perrigo (PRGO) has 7 years of Net Equity Issued and Repurchased data on file, last reported at $200000.0 in Q4 2019.
- On a quarterly basis, Net Equity Issued and Repurchased fell 33.33% year-over-year to $200000.0 in Q4 2019; TTM through Dec 2020 was $600000.0, a 68.42% decrease from a year earlier, with the FY2019 full-year figure at $900000.0, down 30.77% from the prior year.
- Net Equity Issued and Repurchased for Q4 2019 stood at $200000.0, down from $400000.0 in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for PRGO reached as high as $6.2 million in Q3 2015 and fell as low as -$1.1 million in Q4 2016.
- Historically, Net Equity Issued and Repurchased has averaged $1.3 million across 5 years, with a median of $350000.0 in 2017.
- Across the five-year window, Net Equity Issued and Repurchased soared 233.33% in 2018 and slumped 60.0% in 2019, its largest moves.
- Year by year, Net Equity Issued and Repurchased stood at $6.2 million in 2015, then tumbled by 117.74% to -$1.1 million in 2016, then jumped by 118.18% to $200000.0 in 2017, then soared by 50.0% to $300000.0 in 2018, then plunged by 33.33% to $200000.0 in 2019.
- Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $200000.0 in Q4 2019, $400000.0 in Q3 2019, and $300000.0 in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 500,000.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 200,000.00 |
| Dec 31, 2019 | 200,000.00 |
| Sep 28, 2019 | 400,000.00 |
| Sep 28, 2019 | 400,000.00 |
| Dec 31, 2018 | 300,000.00 |
| Dec 31, 2018 | 300,000.00 |
| Sep 29, 2018 | 1.00 Mn |
| Sep 29, 2018 | 1.00 Mn |
| Dec 31, 2017 | 200,000.00 |
| Dec 31, 2017 | 200,000.00 |
| Sep 30, 2017 | 300,000.00 |
| Sep 30, 2017 | 300,000.00 |
| Jul 1, 2017 | 200,000.00 |
| Jul 1, 2017 | 200,000.00 |
| Dec 31, 2016 | -1.10 Mn |
| Dec 31, 2016 | -1.10 Mn |
| Apr 2, 2016 | 3.10 Mn |
| Apr 2, 2016 | 3.10 Mn |
| Sep 26, 2015 | 6.20 Mn |
| Sep 26, 2015 | 6.20 Mn |